In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response

Ann Intern Med. 2024 May 7. doi: 10.7326/J24-0022. Online ahead of print.ABSTRACTGiamarellos-Bourboulis EJ, Siampanos A, Bolanou A, et al. Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2024;12:294-304. 38184008.PMID:38710079 | DOI:10.7326/J24-0022

Source: Annals of Internal Medicine - May 6, 2024 Category: Internal Medicine Authors: Henry S Sacks Source Type: research